Mylan Pharmaceuticals, the makers of the EpiPen, spent the past decade making sure that its life-saving allergy product was in as many public schools as possible. But the company has come under fire in recent weeks for raising the price of the drug from roughly $57 in 2007 to about $600 today—all for about $1 worth of medicine
. Now the New York Attorney General’s Office is investigating whether Mylan broke antitrust laws in the contracts it made with schools.
Source: Gizmodo – Do Mylan’s EpiPen Contracts With Schools Break Antitrust Laws?